The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAngle Share News (AGL)

Share Price Information for Angle (AGL)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 15.00
Bid: 14.50
Ask: 15.50
Change: 0.00 (0.00%)
Spread: 1.00 (6.897%)
Open: 15.25
High: 15.25
Low: 14.75
Prev. Close: 15.00
AGL Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Australia shares ease for 4th day as financials drag; NZ higher

Wed, 04th Apr 2018 04:10

* ANZ falls for the eighth straight day

* Fonterra slightly lower after NZ milk production falls inFeb

By Susan Mathew

April 4 (Reuters) - Australian shares eased for a fourthconsecutive day on Wednesday, dampened by weakness in financialstocks, although gains in the defensive healthcare sector cappedoverall losses.

The S&P/ASX 200 index fell 5.7 points to 5,747.2 by0225 GMT. The benchmark closed 0.1 percent lower on Tuesday.

Financials are under pressure as they are a currency proxy,said Mathan Somasundaram, market portfolio strategist, BlueOcean Equities.

"The market is beginning to see a bounce in the U.S. dollarand the Aussie dollar is falling, which means you'll seeexposure reduction by global investors in Australia, and thathits the big banks."

The Aussie is hovering near four-month lows, hurtby the outlook for global growth amid escalating U.S.-Chinatrade tensions.

Australia and New Zealand Banking Group posted itseighth straight losing session, down 1 percent, while otherlenders among the 'Big Four' fell between 0.4 percent and 0.7percent.

Mining giant BHP was marginally higher after havingfallen as much as 0.4 percent. Iron ore on the Daliancommodities exchange snapped a five-day gaining streak onTuesday, and was 1.3 percent lower at 0225 GMT.

Weaker bullion hit gold stocks with Newcrest Miningdropping 1.3 percent.

Rio Tinto and Fortescue Metals, however,edged higher. Fortescue saw a rating upgrade to 'buy' fromDeutsche Bank.

CSL Ltd led gains among healthcare stocks, risingas much as 2 percent, its best one-day gain in more than threeweeks.

"I think that (healthcare) is pretty much a safety play atthis point, as most of the stocks in the healthcare sector likeCSL, Cochlear are way overvalued, if you look at it onhistorical terms," Somasundaram added.

Cochlear, however, was slightly lower for the day.

The biggest power producer in Australia, AGL Energy, rose as much as 0.3 percent, before trading flat afterAlinta Energy, owned by Hong Kong's Chow Tai Fook Enterprises,expressed an interest in acquiring its coal-fired Liddell PowerStation in New South Wales state.

New Zealand's benchmark S&P/NZX 50 index rose 0.2percent, or 16.27 points, to 8,346.2.

Dairy company a2 Milk and Auckland InternationalAirport pushed up the index the most. A2 was up 3percent, while Auckland edged 0.8 percent higher.

The world's biggest dairy exporter Fonterrawas marginally lower after it said its New Zealand milkoutput in February fell 2 percent.

For more individual stocks activity click on(Reporting by Susan Mathew in Bengaluru; Additional reportingby Ambar Warrick;Editing by Jacqueline Wong)

More News
31 Mar 2020 09:40

Angle UK, US, Canada operations 'severely disrupted' by Covid-19

(Sharecast News) - Liquid biopsy company Angle said on Tuesday that operations in the UK, US and Canada had all been "severely disrupted" by the Covid-19 pandemic.

Read more
3 Mar 2020 18:58

Angle Parsortix Test Used To Help Discover Brain Metastasis

Angle Parsortix Test Used To Help Discover Brain Metastasis

Read more
27 Feb 2020 14:09

Angle's Parsortix Beats Others In Assessing Kidney Cancer Patients

Angle's Parsortix Beats Others In Assessing Kidney Cancer Patients

Read more
27 Feb 2020 12:42

Angle upbeat on recent Parsortix research out of Italy

(Sharecast News) - Liquid biopsy company Angle announced on Thursday that Istituto Nazionale Tumori di Milano in Milan, Italy, has published results of work assessing the performance of its 'Parsortix' system in renal cell carcinoma (RCC), demonstrating key advantages of Parsortix.

Read more
17 Feb 2020 15:25

Angle upbeat on German research into 'Parsortix'

(Sharecast News) - Liquid biopsy company Angle announced on Monday that University Medical Centre Hamburg-Eppendorf has published results of work undertaken to assess the analytical and clinical performance of 'Parsortix' in multiple metastatic cancer types, with the main emphasis on metastatic breast cancer.

Read more
11 Feb 2020 10:51

Study Finds Angle's Parsortix Can Predict Melanoma Sufferers Survival

Study Finds Angle's Parsortix Can Predict Melanoma Sufferers Survival

Read more
11 Feb 2020 07:41

Angle upbeat on research into Parsortix with melanoma patients

(Sharecast News) - Liquid biopsy company Angle announced on Tuesday that a customer, the Edith Cowan University in Perth, Western Australia, has published results of research into the use of its 'Parsortix' system with melanoma patients.

Read more
30 Jan 2020 11:41

Angle Loss Widens As It Eyes US Parsotix Cancer Treatment Clearance

Angle Loss Widens As It Eyes US Parsotix Cancer Treatment Clearance

Read more
23 Jan 2020 16:10

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
22 Jan 2020 11:00

Angle Eyes US Consent For Parsortix Cancer Medication In Third Quarter

Angle Eyes US Consent For Parsortix Cancer Medication In Third Quarter

Read more
7 Nov 2019 13:50

Angle Gets Study Results Demonstrating Use Of Parsortix In Melanoma

Angle Gets Study Results Demonstrating Use Of Parsortix In Melanoma

Read more
31 Oct 2019 15:38

Angle Submits Positive Test Results For Parsortix System To US FDA

Angle Submits Positive Test Results For Parsortix System To US FDA

Read more
4 Oct 2019 15:17

Angle upbeat on patent grant for prostate cancer blood assessment

(Sharecast News) - Liquid biopsy company Angle announced on Friday that the Queen Mary University of London (QMUL) European patent covering the measurement of the number of megakaryocytes in a patient blood sample as an assessment of the prognosis for prostate cancer has been granted.

Read more
4 Oct 2019 08:58

Angle Notes Queen Mary University's European Cancer Prognosis Patent

Angle Notes Queen Mary University's European Cancer Prognosis Patent

Read more
4 Sep 2019 14:09

Angle Reports Positive Study Results For Parsortix System

(Alliance News) - Angle PLC on Wednesday noted positive results from a study of its Parsortix system in small cell lung cancer.Parsortix is Angle's liquid biopsy technology, meaning it

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.